{
  "docId": "019de076-48c2-7315-bf77-72d2721572a4",
  "docSlug": "9ba2b11c98152a86fe4ad3555ff50f91",
  "documentTitle": "Immatics | Investor Presentation Deck | 75 slides",
  "authorId": "immatics",
  "authorName": "Immatics",
  "documentKindSlug": "pitchdeck",
  "documentKindLabel": "Pitch deck",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2023-11-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7777778,
  "pageNumber": 6,
  "pageCount": 75,
  "prevPage": 5,
  "nextPage": 7,
  "slideType": "comparison_table",
  "function": "compare_peers",
  "density": "dense",
  "nDataPoints": 0,
  "notes": "The slide uses a process-flow diagram to contrast personalized autologous therapy with off-the-shelf bispecific therapy.",
  "elementsJson": null,
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019de076-48c2-7315-bf77-72d2721572a4/6",
  "deckHref": "/decks/019de076-48c2-7315-bf77-72d2721572a4",
  "deckJsonHref": "/decks/019de076-48c2-7315-bf77-72d2721572a4.json",
  "deckAnchorHref": "/decks/019de076-48c2-7315-bf77-72d2721572a4#slide-6",
  "components": [
    {
      "bbox": {
        "h": 0.72,
        "w": 0.45,
        "x": 0.52,
        "y": 0.135
      },
      "kind": "diagram",
      "text": "TCR Bispecifics (TCER®) process flow",
      "attrs": null,
      "subkind": "process",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "8c6d9c62-ea66-4485-a112-6a397aa221db",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.72,
        "w": 0.45,
        "x": 0.03,
        "y": 0.135
      },
      "kind": "diagram",
      "text": "Autologous TCR-T (ACTengine®) process flow",
      "attrs": null,
      "subkind": "process",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "d8cc6437-2774-4d0e-909b-e2ae78eaa568",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.04,
        "w": 0.6,
        "x": 0.02,
        "y": 0.95
      },
      "kind": "disclaimer",
      "text": "Interim data update from the ACTengine® IMA203/IMA203CD8 monotherapies (published November 08, 2023); Initial manufacturing may provide sufficient quantity for potential repeat dosing.",
      "attrs": null,
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "a5063b01-f60c-4230-8d31-fb6e19021681",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.25,
        "w": 0.25,
        "x": 0.05,
        "y": 0.2
      },
      "kind": "list",
      "text": "Strong clinical activity in patients with high tumor burden; Single dose; Proprietary manufacturing process; Specialized medical centers; Target requirements: stringent tumor selectivity, low, medium, high copy numbers",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "0707abdb-92a0-4998-a529-f0c960dbaa65",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.25,
        "w": 0.22,
        "x": 0.75,
        "y": 0.2
      },
      "kind": "list",
      "text": "Off-the-shelf biologic for immediate treatment; Repeat dosing; All hospitals and out-patient, opportunity for larger patient reach; Favorable commercial characteristics; Target requirements: strong tumor association, median to high copy numbers",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "179a6d14-b391-4a79-aede-56727d268c8d",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.04,
        "w": 0.68,
        "x": 0.16,
        "y": 0.88
      },
      "kind": "title",
      "text": "Differentiated positioning of ACTengine® vs. TCER® based on patient population and medical need",
      "attrs": null,
      "subkind": "action-title",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "84b1274b-a63f-41db-9c34-8cb624f8e8e5",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.06,
        "w": 0.78,
        "x": 0.03,
        "y": 0.05
      },
      "kind": "title",
      "text": "Two Distinct TCR-based Therapeutic Modalities in Clinical Development",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "2654a4c4-be40-4ae6-b6e6-1f3fb7e68a90",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [],
  "frameworks": [
    {
      "name": "comparison_frame",
      "slug": null,
      "matchId": "45fd8698-1760-4607-9dfc-22fc3a3a96a3",
      "evidence": "Side-by-side comparison of two distinct therapeutic modalities",
      "confidence": 0.9
    }
  ],
  "arcBeats": [
    {
      "to": 14,
      "from": 5,
      "beatId": "1a48f66b-df9b-4c34-b767-f8966527abea",
      "arcName": "The Sequoia Pitch",
      "arcSlug": "sequoia-pitch",
      "beatName": "Solution",
      "beatSlug": "sequoia-pitch-solution",
      "evidence": "The solution is presented in the solution and comparison table sections.",
      "position": 1,
      "confidence": 0.8,
      "parentBeatName": "Turn",
      "parentBeatSlug": "turn"
    }
  ],
  "loops": [],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}